COVID-19 infection may have a negative impact on the cardiovascular system by potentially causing myocardial damage, vascular inflammation, and myocardial infarction. The presence of myocardial injury is a poor prognostic sign.
Electrocardiogram, a simple bedside diagnostic test with high prognostic value, and continuous ECG monitoring can be employed to assess early cardiovascular involvement in such patients and to rapidly detect life-threatening arrhythmias and/or impending clinical deterioration.
In this podcast, we will discuss the central role of 12-lead ECG and continuous ECG monitoring in COVID-19 patients. In particular, this podcast will provide practical insights and clinical protocols that can assist physicians in managing high-risk COVID-19 patients.